Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose–response study
- 30 April 2011
- journal article
- research article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 95 (5), 1725-1729.e8
- https://doi.org/10.1016/j.fertnstert.2010.11.068
Abstract
No abstract availableKeywords
Funding Information
- EMD Serono
- Merck KGaA
This publication has 18 references indexed in Scilit:
- New advances in ovulation inductionCurrent Opinion in Obstetrics and Gynecology, 2007
- A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertilityGynecological Endocrinology, 2007
- A new era in ovulation inductionFertility and Sterility, 2006
- Single-dose administration of an aromatase inhibitor for ovarian stimulationFertility and Sterility, 2005
- A phase I study of the pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose anastrozole in healthy, premenopausal female volunteersFertility and Sterility, 2004
- AnovulationBMJ, 2003
- Aromatase inhibitors for the treatment of infertilityExpert Opinion on Investigational Drugs, 2003
- Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor respondersFertility and Sterility, 2002
- Antiestrogenic effect of clomiphene citrate in a multiple follicular stimulation protocolJournal of Assisted Reproduction and Genetics, 1986
- Ovulation and Pregnancy Rates With Clomiphene CitrateObstetrics & Gynecology, 1978